Treatments currently in Research and Development

 

For: Nausea Relief
Objective: Help ease the nausea and vomiting that chemo-bound cancer or AIDS patients experience


 

For: Nerve Pain Relief

Objective: Help quell the burning pain in the feet and hands caused by diabetes, AIDS, spinal cord injuries, and other conditions


 

For: Multiple Sclerosis
Objective: Control the debilitating muscle spasms and stiffness, which often interfere with sleep and even walking



For: General Chronic Pain Relief

Objective: Ease the pain from cancer and other conditions like severe headaches, arthritis, and some kinds of back injuries that aren't nerve-related


 

For: Epilepsy

Objective: Reduce the number of seizures in children and adults with Dravet Syndrome and Lennox-Gastaut Syndrome, types of epilepsy that are difficult to control with current medications


 

For: Crohn's Disease
Objective: Ease the need for medication and surgery for patients with this type of inflammatory bowel disease, which often irritates the small intestine.
.


 

For: Cancer Treatment
Objective: Slow or halt the growth of cancer cells


 

For: Parkinson's Disease
Objective: Reduce the tremors in this nervous system disorder as well as the stiffness in the arms and legs


 

For: Alzheimer's Disease
Objective: Help slow down the progression of this condition—or prevent it


 

For Anxiety Disorders

Objective: Reduce stress in social situations
Effectiveness Grade: C


 

For: Post-Traumatic Stress Disorders
Objective: Ease the nightmares and other symptoms of PTSD


 

For: Weight Loss
Objective: Drop a few pounds by kicking up metabolism


 

For: Lupus
Objective: Help reduce pain—especially joint aches—in patients with this autoimmune disorder and prevent the disease from progressing


 

For: Glaucoma

Objective: Lower pressure within the eye, reducing the progression of the disease

Valley Medical Group (VMG) takes advantage of its unique understanding of metabolic processes to provide innovative treatment options for unmet medical needs.

Cannabis use has an extensive history dating back thousands of years, and currently there are thousands of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate.

At Valley Medical, we use an inquiring approach to discover and develop novel cannabinoid-based therapies to improve patients’ lives. From the initiation, our founders have been committed to fostering and maintaining a bold, pioneering spirit fostering the true nature of innovation from which cutting edge ideas flourish and translate into evidence-based solutions.

We are dedicated to working closely with local, national and international regulatory agencies to provide access to high quality, first class cannabinoid pharmaceuticals to those critically in need of new treatments for life threatening and debilitating conditions. Valley Medical’s clinical trial material comes from the cultivation and production facilities that are cGMP compliant, surpassing high quality standard industrial and food processing requirements.

The Company works with staff and leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize novel therapeutic approaches for the treatment of multiple critical ailments from cancer and infections to age-related illnesses and neurobehavioral disorders.

Our products, broadly described, are medical cannabinoid formulations developed from one or more of the cannabinoid compounds found in the cannabis plant. Our immediate focus is to treat one of the most important diseases in the world, cancer.

 

BASIS & PHILOSOPHY

Cannabis plants have extensive history of medical and agricultural use dating back thousands of years.

To date hundreds of natural constituents covering several chemical classes have been isolated and identified from the Cannabis plant.

SOME KEY PHYTOCANNABINOIDS ARE:

  • tetrahydrocannabinol (THC)
  • cannabidiol (CBD)
  • cannabigerol (CBG)
  • cannabichromene (CBC)
  • cannabinol (CBN)

These cannabinoids belong to the chemical class of terpenophenolics, of which 85 have been uniquely identified in cannabis, including the most psychoactive cannabinoid, THC. Some applications of cannabinoids have been well established in peer-reviewed literature such as for alleviating nausea and stimulating the appetite for people with AIDS and cancer. Other well-known uses include easing chronic pain and reducing muscle spasms associated with multiple sclerosis and spinal cord injuries.

The pharmacology of THC has been widely studied, while many other identified cannabinoids are still poorly characterized pharmacologically and biologically, with new activities for cannabinoids consistently being discovered.

Valley Medical is developing novel cannabis based approaches to treat the world’s most deadly illnesses. We learn from patients about the healing properties of cannabis medicines. Our immediate focus is the development of cutting edge cancer treatments.

The Company’s future endeavors include infectious illnesses, neurobehavioral disorders including attention deficit disorder, post-traumatic stress disorder; and an application of the anti-inflammatory activities of cannabis in the management of age-related illnesses.

The endocannabinoid system possessed by all vertebrates regulates all body systems and maintains homeostasis. As such, the mechanisms of phytocannabinoids’ biological impact are multidimensional.

While concentrating on our core activities of discovering and developing treatments that will make a meaningful difference in patients’ lives, we remain mindful that we have other responsibilities to the clinicians who utilize our drugs, health authorities around the world, our shareholders, our employees, and the communities in which we live and work. We continually strive to improve our corporate responsibility standards and activities, implementing comprehensive ethical standards and undertaking patient and community progressive initiatives.

These principles reflect the mission of Valley Medical to provide innovative therapeutics for unmet medical needs.

As the industry leader, Valley Medical consults and leads other emerging businesses that Cannabis Science believes has a preferred business model, one which will mature into a key business model in the future. Our consulting is on the entire "seed to sale" process with a focus on bio-pharmaceutical development.

Valley Medical is one of the longest standing companies in the cannabis business.

We feel that the correct way is to look at the industry from a bio-pharmaceutical standpoint, in a manner that allows cannabinoid-based products to modulate the endocannabinoid system to treat multiple conditions. Scientifically, we know this is the beginning of one of the greatest expansions of medicine and industry we will ever experience in our lifetime.

Coming Soon

 CEO  

 D.G. Tatum

Serving in both the U.S. Military and the intelligence Community, Mr. Tatum has garnered contacts around the world. A graduate of the Univ of Maryland in Psychology, the University of Nebraska with an Advanced degree in Clinical Psychology, the university of Padova School of Medicine, and the U.S. Military School of Aviation Medicine, Houston, Texas, Mr. Tatum brings an area of expertise rarely found in the private sector. 

 

 Chief Legal Representative

   Ulises Blanco Diez
     

 

Director of Natural Medicine

Charles Lewis ND

As an undergraduate Charles Lewis, ND, was a candidate for the “Institutions and Policy Oxbridge Tutorial Series” (Rhodes program) at Cambridge. He is a board certified naturopath, by the American Naturopathic Medical Certification and Accreditation Board, with post-doctoral studies in biological medicine through the Marion Foundation, directed by Dr. Thomas Rau, from the Paracelsus Klinik, Switzerland.

Former professor of pre-med and nursing anatomy at Lake Michigan College, and Dean of Science at Sherman Institute. Recruited by the State of Oklahoma Director of Veterinary Medicine to help mediate the outbreak of WNV (West Nile virus) at OKC Equine Clinic in 2002/2003.


     
     
     
     
     

 

Cannabinoids have an extensive history dating back thousands of years, and currently there are thousands of peer-reviewed scientific publications that document the underlying biochemical pathways that cannabinoids modulate. The endocannabinoid system possessed by all vertebrates regulates all body systems and maintains homeostasis. As such, the mechanisms of phytocannabinoids’ biological impact are multidimensional.

Some applications of cannabinoids have been well established in peer-reviewed literature such as alleviating nausea and stimulating the appetite for people with AIDS and Cancer. Other well-known uses include easing chronic pain and reducing muscle spasms associated with neuromuscular disorders like MS and spinal cord injuries. Some current uses are poorly understood, such as its perceived effectiveness in alleviating certain autoimmune disorders, such as Crohn’s Disease.

Our team of scientists will produce and commercialize products derived from cannabis-based botanical extracts. Even today, new uses for cannabinoids are consistently discovered. For example, scientists recently found that topical cannabinoid-based preparations can be effective against MRSI, the deadly antibiotic-resistant flesh-eating disease. Other topical applications, which are largely non-psychoactive, would target localized pain, such as arthritis and burns, as well as neuropathic pain, for which there are few effective treatments.

In 2001, an article published in the Canadian Medical Association Journal revealed that, based on self-identified needs, it is estimated that 2% (or 400,000) of Canadian adults were already utilizing cannabinoids for medical purposes. With ever increasing use and scientific support for cannabinoid medicines occurring in the US and around the world, we are looking at a new multi-billion dollar industry that will play a dramatic role that will impact human health on a global scale.

Media

Click Here United States Patent on Cannabis 

 

 

 

 

Great true story on the Medical Advantages

 

 

INVESTMENT CERTIFICATIONS AND DONATIONS



 

 

 

Financial Report

 

January 28, 2016 Updated Financial and Investor information 2 September 2016

 

 

This section was updated on 2 September 2016 due to a new certification of our test grow of Medical Cannabis in our Farm # 3 in Monteria Colombia.

The Colombian Government has taken random samples of our test grow of 1,000 medical grade cannabis plants. The reason for this random sampling is to determine the viability of our production as medical grade plants and the quality of such.

 

The following represents the results and market price as determined by FNE of Colombia, the controlling entity for controlled substances.

 

Authorized Hectares for growing fields: 20

Authorized plants per Hectare: 8,000

Flower yield per plant: 3 to 5 pounds

Graded extracted oil per ounce of flower: 3 to 4 grams

Market price as determined by grade of extracted oils: $120,000 to $180,000 Colombian Pesos ($40 to $60 USD )

Based on the above data as provided by our official certification, the following report is offered: (We are using the minimum values as provided by the Colombian certification)

 

8,000 plants per hectare
     x 3 pounds of flower per plant
=24,000 pounds of Flower

      x 16 ounces per pound
=384,000 ounces
        x 3 grams per ounce
=1,152,000 grams of  Oil
        x $40 per gram
=$46,080,000 USD per one Hectare per quarter.

 

VMG is in the process of preparing 3 Hectares for planting. Each growing period for a mature plant is 3 to 4 months. Planting schedule is one hectare per quarter providing an evenly spaced yield of 9 harvests per year. We need investors to help grow this project.

 

Donations

Thank you for your interest in Valley Med. At Valley Med we value you. We accept donations for the furtherment of research and development.

To Donate to the effort click the donate button below

 

 

Investments

Investment may be made via Check, Money Order, or Credit Card. Please contact us for registration. If you wish your investment to remain anonymous or in a company name, that is acceptable. Simply click below and fill out the contact form and we will get back to you.

 

 Investors that want to become a part owner of VMG

  • VMG is currently offering 500,000 shares of private company stock to investors. Shares are valued at $50 per share. We will increase the value per share  once we have either:
    1. Sold the first 20,000 shares
    2. Board of Directors determination that an increase is justified
  • Currently stock values are $50 per share. 

Click Here To Contact Us

Valley Medical Group
This email address is being protected from spambots. You need JavaScript enabled to view it.

 

INVESTMENT AND DONATIONS

 

Donations

Thank you for your interest in Valley Med. At Valley Med we value you. We accept donations for the furtherment of research and development.

To Donate to the effort click the donate button below

 

 

Financial Report

 

January 28, 2016 Updated Financial and Investor information 2 September 2016

 

 

This section was updated on 2 September 2016 due to a new certification of our test grow of Medical Cannabis in our Farm # 3 in Monteria Colombia.

The Colombian Government has taken random samples of our test grow of 1,000 medical grade cannabis plants. The reason for this random sampling is to determine the viability of our production as medical grade plants and the quality of such.

 

The following represents the results and market price as determined by FNE of Colombia, the controlling entity for controlled substances.

 

Authorized Hectares for growing fields: 20

Authorized plants per Hectare: 8,000

Flower yield per plant: 3 to 5 pounds

Graded extracted oil per ounce of flower: 3 to 4 grams

Market price as determined by grade of extracted oils: $120,000 to $180,000 Colombian Pesos ($40 to $60 USD )

Based on the above data as provided by our official certification, the following report is offered: (We are using the minimum values as provided by the Colombian certification)

 

8,000 plants per hectare
     x 3 pounds of flower per plant
=24,000 pounds of Flower

      x 16 ounces per pound
=384,000 ounces
        x 3 grams per ounce
=1,152,000 grams of  Oil
        x $40 per gram
=$46,080,000 USD per one Hectare per quarter.

 

VMG is in the process of preparing 3 Hectares for planting. Each growing period for a mature plant is 3 to 4 months. Planting schedule is one hectare per quarter providing an evenly spaced yield of 9 harvests per year. We need investors to help grow this project.

 

Investments

Investment may be made via Check, Money Order, or Credit Card. Please contact us for registration. If you wish your investment to remain anonymous or in a company name, that is acceptable. Simply click below and fill out the contact form and we will get back to you.

 

1. Investors that want to become a part owner of VMG

  • VMG is currently offering 500,000 shares of private company stock to investors. Shares are valued at $50 per share. We will increase the value per share  once we have either:
    1. Sold the first 20,000 shares
    2. Board of Directors determination that an increase is justified
  • Currently stock values are $50 per share. 

Click Here

CLICK HERE TO INVEST TODAY. MINIMUM INVESTMENT IS $50
Click here to invest with us

INITIAL OFFERING,

VMG Shares Available Round One @ $50 per share 
(10,000 Shares Available)

WE ARE CURRENTLY ACCEPTING INVESTMENTS.

MINIMUM INVESTMENT IS $50 USD. ALL INVESTORS RECEIVE 1 SHARE OF VMG STOCK PER $50 INVESTMENT.
All Shares are electronic as is Industry Standard

 

Proposed Medical Marijuana Production Facility

In Formation: The Valley Farms Medical Group SAS.  Private Stock 1,000,000 Shares

Stock Availability 500,000 Shares  

Initial Stock Offer:
$50/share with quarterly dividends.

Current Stock Offer:

$50/share with quarterly dividends. 

Stock Holding period: 1 year

To invest send us an email at This email address is being protected from spambots. You need JavaScript enabled to view it. we will send you an invoice with payment information.

 


Colombia Approves Medical Marijuana

On 22 December 2015, Colombia's president has signed a decree fully legalizing medical marijuana in a shift away from preventing drug crop production.

Juan Manuel Santos said the move put Colombia "in the group of countries that are at the forefront...in the use of natural resources to fight disease".

But, he said, the country would still fight illegal drug production. Up until now, marijuana production in Colombia had fallen into a legal grey area.While a 1986 law allowed for the manufacture, export, sale and medical and scientific use of marijuana, the practice was, until Tuesday, never formally regulated.

Anyone wishing to grow marijuana must now apply to the National Narcotics Council for a licence. Medical marijuana is used for medical ailments such as Crohn's disease, seizures, HIV and nausea.

Last year, Mr Santos, who has admitted smoking cannabis while a student in Kansas in the 1970s, said legalization would take drug production out of the hands of drug traffickers.

In addition the U.S. Senate today passed the FY2016 Military Construction and Veterans Affairs (MilCon-VA) Appropriations Bill, which includes language to allow Veterans Administration (VA) doctors to recommend medical marijuana to their patients in states where medical marijuana is legal. The language was included as an amendment in the Senate Appropriations committee in May.

“Veterans in medical marijuana states should be treated the same as any other resident, and should be able to discuss marijuana with their doctor,” said Michael Collins, deputy director of national affairs for the Drug Policy Alliance. “It makes no sense that a veteran can’t use medical marijuana if it helps them and it is legal in their state.”


 U.S. approves States rights to Medical Marijuana

 Under the provision, states where medical pot is legal would no longer need to worry about federal drug agents raiding retail operations. Agents would be prohibited from doing so.

We are in the process of putting together a small investment group to go forward with the construction and production of facilities including growing fields.

We are not limiting the growing fields to our Cordoba farms as the quality for Medical Marijuana may require other varying environmental conditions for the best results. We are currently investigating six zones in Colombia to determine the best area for the product.

Statistics show that historically one meter of land will produce between 400 to 500 grams of cannabis buds. The cost to grow and process cannabis in Colombia is from $2.50 to 3.50/lb, and world average price is $2000-5000/lb. 

Extracting cannabis oils (CDB and THC) adds a new dimension to sales. The extraction process is estimated at one pound of trim produces 28 grams of concentrate.

Concentrate will be processed into varying strengths of Vape capable oil.

Dry Cannabis products will be rolled int cigarettes and packaged at 5 sticks per pack or 20 stick per package

Our sources say Cannabis oil retails for around $50 per gram, with wholesale rates of $20 to $30 per gram. The pound rate—if it exists—would be $9,000 wholesale or more. Therefore 72 ounces of liquid Cannabis oil would carry a $40,000 price tag.

Outdoor production: one plant per square meter

Indoor Production 4 plants per square meter

Proposed production facility: Valley Medical Group proposes to build laboratory and production facilities in the Rio Negro Free Zone, thus allowing High Security and untaxable worldwide shipping.

Our Species: Cannabis sativa
                 
  Indica Kryptonite

Growing Fields

Cordoba, Colombia 100 Hectares available (There are 10,000 Square Meters per Hectare).

Cauca, Colombia 50 Hectares Available

 

Target Market

Valley Medical Group sells only to approved dispensaries and pharmacies.

Markets include dispensary and pharmacy locations around the world to include the United States Veterans Administration. Controlled production allows for a medically sound product. 

 

Investment Data Due Diligence

Investing in Colombia Companies (This explains the SAS Corporations)

Marijuana Business Factbook from 2013 (Things have changed for the best in the last 2 years)

Legal in Colombia

Medical Marijuana Approved States

Cannibis in Colombia

Colombia Cannibis Top Ten in Quality


Warning: Invalid argument supplied for foreach() in /home/vmgco/public_html/plugins/system/helix/shortcodes/carousel.php on line 31

 

About us

  • valley medical group, valley medical group, valley medical group, valley medical group, valley medical group, valley medical group, valley medical group, valley medical group,Medical Marijuana Colombia,Medical Marijuana Colombia,Medical Marijuana Colombia

    Valley Medical is a licensed Pharmaceutical Manufacturer and Medical Research and development company. We currently hold licenses in the manufacturing industry of controlled substances thru the schedule II category. Substances categorized under the Schedule I catagory are authorized for research by Valley Medical on a case by case basis in our laboratories in Colombia.

    Valley Medical is not bound by the United States Sanction on scientific studies on the medical applications of Cannabis. The Colombian government supports studies on new medical advancements in the use of various plants as medicines.

    Valley Medical Group is a Private Corporation formed under Colombian law as a Simplified shares corporation (SAS)  founded in 2016 in order to provide reliable access to high quality medical marijuana products that they can trust. 

    Read more...

Sign up for our free Newsletter

Please consider supporting our efforts. Research and Development can save lives and improve quality of life.

: